Improving access to clinical trials for lung cancer patients

Improving Access and Recruitment to Clinical Trials for Lung Cancer Patients

NA · Oxford Brookes University · NCT05888584

This study is trying to see if giving lung cancer nurses better tools and training can help more patients join clinical trials for new treatments.

Quick facts

PhaseNA
Study typeInterventional
Enrollment100 (estimated)
Ages18 Years and up
SexAll
SponsorOxford Brookes University (other)
Locations9 sites (Derby, Derbyshire and 8 other locations)
Trial IDNCT05888584 on ClinicalTrials.gov

What this trial studies

This study aims to enhance the recruitment of lung cancer patients into clinical trials by developing a research readiness tool for lung cancer nurses. It addresses the low participation rates in clinical trials, which were only 8% in the UK in 2021/22, by exploring barriers to recruitment and providing nurses with the necessary resources and training to discuss trial participation with patients. The study will involve multiple phases, including assessing current practices and testing the effectiveness of the new tool in improving discussions about clinical trials. Ultimately, the goal is to increase patient access to new treatments and improve their overall care experience.

Who should consider this trial

Good fit: Ideal candidates include lung cancer patients of any stage who are under the care of participating NHS Trusts.

Not a fit: Patients with a diagnosis of mesothelioma or those unable to provide informed consent may not benefit from this study.

Why it matters

Potential benefit: If successful, this initiative could significantly increase lung cancer patients' access to innovative treatments and improve their quality of life.

How similar studies have performed: While there have been efforts to improve clinical trial recruitment, this specific approach focusing on enhancing nurse-patient discussions is relatively novel.

Eligibility criteria

Show full inclusion / exclusion criteria
Healthcare staff Phase 2:

Inclusion Criteria:

* Actively involved in the clinical care pathways of lung cancer patients
* Working at one of the six participating NHS trusts
* Age between 18-65 years of age

Exclusion criteria:

* Not actively involved in frontline clinical care
* Not involved in caring for lung cancer patients for at least 30% of their

Patients/carers:

Inclusion criteria:

* Must have a current diagnosis of lung cancer (any stage) or be the named carer of a person with a lung cancer diagnosis
* Under the care of (or caring for) one of the participating NHS Trusts lung cancer teams
* Aged 18 or over

Exclusion criteria:

* Mesothelioma diagnosis or caring for someone with a mesothelioma diagnosis
* Unable to provide informed consent

Phase 4 Healthcare professionals

Inclusion criteria:

* Registered nurse with Nursing and Midwifery Council
* Actively involved in the clinical care pathways of lung cancer patients
* Working at one of the six participating NHS trusts
* Age between 18-65 years of age

Exclusion criteria:

* Not actively involved in frontline clinical care
* Not involved in caring for lung cancer patients for at least 30% of their role
* Employed as a lung cancer research delivery nurse

Patients/carers:

Inclusion criteria:

* Current diagnosis of lung cancer (any stage) or be the named carer of a person with a lung cancer diagnosis
* Aged 18 or over
* Consented to (or carer of someone who has consented to) a clinical trial since start of pilot study
* Receiving care (or carer for someone receiving care) in one of the four NHS sites piloting the research readiness tool

Exclusion criteria:

* Mesothelioma diagnosis or caring for someone with a mesothelioma diagnosis
* Unable to provide informed consent

Where this trial is running

Derby, Derbyshire and 8 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.

View on ClinicalTrials.gov →

Conditions: Lung Cancer, lung cancer, nurses, research, clinical trials, recruitment, access

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.